Y
Yapu Zhao
Researcher at Nankai University
Publications - 6
Citations - 158
Yapu Zhao is an academic researcher from Nankai University. The author has contributed to research in topics: Antigen & Natural killer T cell. The author has an hindex of 5, co-authored 6 publications receiving 121 citations. Previous affiliations of Yapu Zhao include Tianjin Medical University.
Papers
More filters
Journal ArticleDOI
Vγ4 γδ T Cell-Derived IL-17A Negatively Regulates NKT Cell Function in Con A-Induced Fulminant Hepatitis
Na Zhao,Jianlei Hao,Yuanyuan Ni,Wei Luo,Ruifang Liang,Guangchao Cao,Yapu Zhao,Puyue Wang,Liqing Zhao,Zhigang Tian,Richard A. Flavell,Zhangyong Hong,Jihong Han,Zhi Yao,Zhenzhou Wu,Zhinan Yin +15 more
TL;DR: A novel function of Vγ4 γδ T cells is demonstrated in mediating a protective effect against Con A-induced fulminant hepatitis through negatively regulating function of NKT cells in an IL-17A–dependent manner, and transferring Vγ 4 γ Δ T cells may provide a novel therapeutic approach for this devastating liver disease.
Journal ArticleDOI
Aluminum hydroxide colloid vaccine encapsulated in yeast shells with enhanced humoral and cellular immune responses.
Hui Liu,Zhenghu Jia,Chengmao Yang,Mei Song,Zhe Jing,Yapu Zhao,Zhenzhou Wu,Liqing Zhao,Dongsheng Wei,Zhinan Yin,Zhangyong Hong +10 more
TL;DR: This very uniform hybrid Alum particulate system could have important application as a vaccine carrier to stimulate humoral and cellular immune responses at the same time.
Journal ArticleDOI
A novel antigen delivery system induces strong humoral and CTL immune responses.
Zishan Yang,Miaomiao Xu,Zhenghu Jia,Yuting Zhang,Li Wang,Hongru Zhang,Jingya Wang,Mei Song,Yapu Zhao,Zhenzhou Wu,Liqing Zhao,Zhinan Yin,Zhangyong Hong +12 more
TL;DR: Treatment with β-glucan particles significantly prevented the growth of implanted EG7-OVA tumors in a prophylactic and pre-established tumor model, suggesting that this strategy may be able to be utilized as a promising platform for cancer immunotherapy.
Journal ArticleDOI
ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth
Qiuying Li,Yu Sun,Bowen Liu,Jiabo Li,Xin Hao,Weizhi Ge,Xuemei Zhang,Shiqi Bao,Jianmiao Gong,Zhenhuan Jiang,Chuanjiang Qiu,Liqing Zhao,Yapu Zhao,Yue Chen,Xuejun Yang,Yahui Ding,Zhenzhou Wu +16 more
TL;DR: Patients with activated NF-κB signaling should be given priority for enrollment in future phase II clinical trials, as the underlying mechanisms of a new orphan drug, ACT001, significantly suppressed glioma cell proliferation and induced apoptosis and cell cycle arrest in vitro.
Journal ArticleDOI
IL-4 induces a suppressive IL-10-producing CD8+ T cell population via a Cdkn2a-dependent mechanism.
Yapu Zhao,Yapu Zhao,Huiyuan Zhao,Yuehong Sun,Jianlei Hao,Xiaofei Qi,Xinglong Zhou,Zhenzhou Wu,Puyue Wang,Susan M. Kaech,Casey T. Weaver,Richard A. Flavell,Liqing Zhao,Zhi Yao,Zhinan Yin +14 more
TL;DR: A population of IL‐10‐producing CD8+ Tregs induced by IL‐4 and mediated by Cdkn2a is defined, indicating a critical role of this population of CD8- T cells in regulatory immune responses.